A

Avenge Bio

22 employees

AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2019

Funding rounds raised

Total raised

$45M

from 4 investors over 4 rounds

A

Avenge Bio raised $45M on January 5, 2022

Investors: Perceptive Advisors, Pappas Capital and Longitude Capital

A

Avenge Bio raised undisclosed on March 30, 2020

Investors: Longitude Capital

FAQ